Business

Outcomes-Based Contracting for Disease-Modifying Therapies in Multiple Sclerosis: Necessary Conditions for Paradigm Adoption

Cori Gray, PharmD, James T. Kenney, RPh, MBA

December 2019 Vol 12, No 8 - Business, Original Article

Stakeholder Perspective

Outcomes-Based Contracts Gaining Traction: Innovative Therapies Will Require Innovative Payment Methods

by Gary Branning, MBA

Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia

David Campbell, PharmD, MS, Marlo Blazer, PharmD, BCOP, Lisa Bloudek, PharmD, MS, John Brokars, MS, Dinara Makenbaeva, MD, MBA

November 2019 Vol 12, No 7 - Business, Business, Original Research, Original Research

Stakeholder Perspective

The Challenges in Budgeting Potential Savings with the Launch of Generic Drugs

by James T. Kenney, RPh, MBA

The Economic Implications of Hyperkalemia in a Medicaid Managed Care Population

Nihar R Desai, MD, MPH, Pamala Reed, DrPH, MPH, Paula J Alvarez, RPh, MBA, MPH, Jeanene Fogli, PhD, RD, Steven D Woods, PharmD, Mary Kay Owens, RPh, CPh

November 2019 Vol 12, No 7 - Business, Original Research

Stakeholder Perspective

The Impact of Quality Care on a Medicaid Population with Hyperkalemia

by Byron C. Scott, MD, MBA

Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States

Michael C. Runken, PharmD, Joshua M. Noone, PhD, Christopher M. Blanchette, PhD, MBA, Emily Zacherle, MS, Reuben Howden, PhD

October 2019 Vol 12, No 6 - Business, Original Research

Stakeholder Perspective

Shared Decision-Making and Payer Preferences: IVIG or SCIG Route of Administration?

by Gary M. Owens, MD

Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer

Krishna Tangirala, MPH, Sreevalsa Appukkuttan, MPH, MBBS, Stacey Simmons, MD

October 2019 Vol 12, No 6 - Business, Original Research

Stakeholder Perspective

The Challenges in Budgeting Potential Savings with the Launch of Generic Drugs

Clinical and Budget Impact of Increasing Colorectal Cancer Screening by Blood- and Stool-Based Testing

Joshua A. Roth, PhD, MHA, Theo deVos, PhD, Scott D. Ramsey, MD, PhD

September 2019 Vol 12, No 5 - Business, Original Research

Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models

Thomas Lodise, PhD, PharmD, Kenneth LaPensee, PhD, MPH

June/July 2019 Vol 12, No 4 - Business, Original Research

Prevalence and Economic Burden of Epilepsy in the Institutionalized Medicare Fee-for-Service Population

Kathryn Fitch, RN, MEd, Xiaoyun Pan, MS, PhD, Jocelyn Lau, MPH, Tyler Engel, ASA, MAAA, Krithika Rajagopalan, MS, PhD

May 2019 Vol 12, No 3 - Business, Original Research

The Economic Value of Customized versus Off-the-Shelf Knee Implants in Medicare Fee-for-Service Beneficiaries

Mary I. O’Connor, MD, Brittany E. Blau, MPH

April 2019 Vol 12, No 2 - Business, Original Research

The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab

Diana Brixner, RPh, PhD, Gary Oderda, PharmD, MPH, Joseph Biskupiak, PhD, MBA, Douglas S. Burgoyne, PharmD, FAMCP, Steven G. Avey, RPh, MS, FAMCP, Steven R. Feldman, MD, PhD

February 2019 Vol 12, No 1 - Business, Case Study, Online First

12 3 4 5 6 7 8 9 10 »End

Page 1 of 14
Results 1 - 10 of 134